Literature DB >> 19177559

Engineering antibody fragments to fold in the absence of disulfide bonds.

Min Jeong Seo1, Ki Jun Jeong, Clinton E Leysath, Andrew D Ellington, Brent L Iverson, George Georgiou.   

Abstract

Disulfide bonds play a critical role in the stabilization of the immunoglobulin beta-sandwich sandwich. Under reducing conditions, such as those that prevail in the cytoplasm, disulfide bonds do not normally form and as a result most antibodies expressed in that compartment (intrabodies) accumulate in a misfolded and inactive state. We have developed a simple method for the quantitative isolation of antibody fragments that retain full activity under reducing conditions from large mutant libraries. In E. coli, inactivation of the cysteine oxidoreductase DsbA abolishes protein oxidation in the periplasm, which leads to the accumulation of scFvs and other disulfide-containing proteins in a reduced form. Libraries of mutant scFvs were tethered onto the inner membrane of dsbA cells and mutants that could bind fluorescently labeled antigen in the reducing periplasm were screened by Anchored Periplasmic Expression (APEx; Harvey et al., Proc Natl Acad Sci USA 2004;101:9193-9198.). Using this approach, we isolated scFv antibody variants that are fully active when expressed in the cytoplasm or when the four Cys residues that normally form disulfides are substituted by Ser residues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19177559      PMCID: PMC2708069          DOI: 10.1002/pro.31

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  41 in total

1.  In vitro and in vivo redox states of the Escherichia coli periplasmic oxidoreductases DsbA and DsbC.

Authors:  J C Joly; J R Swartz
Journal:  Biochemistry       Date:  1997-08-19       Impact factor: 3.162

2.  In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an "undruggable" class of disease targets.

Authors:  Michela Visintin; Teresa Melchionna; Isabella Cannistraci; Antonino Cattaneo
Journal:  J Biotechnol       Date:  2008-03-04       Impact factor: 3.307

3.  Antibody scFv fragments without disulfide bonds made by molecular evolution.

Authors:  K Proba; A Wörn; A Honegger; A Plückthun
Journal:  J Mol Biol       Date:  1998-01-16       Impact factor: 5.469

4.  Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin.

Authors:  S F Little; S H Leppla; E Cora
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

5.  Substitution of charged residues into the hydrophobic core of Escherichia coli thioredoxin results in a change in heat capacity of the native protein.

Authors:  J E Ladbury; R Wynn; J A Thomson; J M Sturtevant
Journal:  Biochemistry       Date:  1995-02-21       Impact factor: 3.162

6.  A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding.

Authors:  K Proba; A Honegger; A Plückthun
Journal:  J Mol Biol       Date:  1997-01-17       Impact factor: 5.469

7.  A periplasmic fluorescent reporter protein and its application in high-throughput membrane protein topology analysis.

Authors:  Jun Jeong Ki; Yasuaki Kawarasaki; Jangsik Gam; Barrett R Harvey; Brent L Iverson; George Georgiou
Journal:  J Mol Biol       Date:  2004-08-20       Impact factor: 5.469

8.  Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivation.

Authors:  Francesca Gennari; Smita Mehta; Yang Wang; Aimée St Clair Tallarico; Giorgio Palu; Wayne A Marasco
Journal:  J Mol Biol       Date:  2004-01-02       Impact factor: 5.469

9.  Engineered DsbC chimeras catalyze both protein oxidation and disulfide-bond isomerization in Escherichia coli: Reconciling two competing pathways.

Authors:  Laura Segatori; Paul J Paukstelis; Hiram F Gilbert; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

10.  Internal protein motions, concentrated glycerol, and hydrogen exchange studied in myoglobin.

Authors:  D B Calhoun; S W Englander
Journal:  Biochemistry       Date:  1985-04-09       Impact factor: 3.162

View more
  6 in total

1.  Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV.

Authors:  Sarah B Lloyd; Keith P Niven; Ben R Kiefel; David C Montefiori; Arnold Reynaldi; Miles P Davenport; Stephen J Kent; Wendy R Winnall
Journal:  Hum Vaccin Immunother       Date:  2017-09-26       Impact factor: 3.452

2.  Exploiting cross-reactivity to neutralize two different scorpion venoms with one single chain antibody fragment.

Authors:  Lidia Riaño-Umbarila; Gabriel Contreras-Ferrat; Timoteo Olamendi-Portugal; Citlalli Morelos-Juárez; Gerardo Corzo; Lourival D Possani; Baltazar Becerril
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

3.  Protein aggregation profile of the bacterial cytosol.

Authors:  Natalia S de Groot; Salvador Ventura
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

Review 4.  Strain engineering for improved expression of recombinant proteins in bacteria.

Authors:  Tomohiro Makino; Georgios Skretas; George Georgiou
Journal:  Microb Cell Fact       Date:  2011-05-14       Impact factor: 5.328

5.  Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.

Authors:  Milda Pleckaityte; Corinna M Bremer; Alma Gedvilaite; Indre Kucinskaite-Kodze; Dieter Glebe; Aurelija Zvirbliene
Journal:  BMC Biotechnol       Date:  2015-09-15       Impact factor: 2.563

6.  Continuous directed evolution of proteins with improved soluble expression.

Authors:  Tina Wang; Ahmed H Badran; Tony P Huang; David R Liu
Journal:  Nat Chem Biol       Date:  2018-08-20       Impact factor: 15.040

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.